News

Article October 17, 2024

A New Era of Treating Neurological Diseases at the Blood-Brain-Immune Interface

Gladstone scientists say it’s time to think differently about how to define and treat diseases such as Alzheimer’s and multiple sclerosis.

News Release Research (Publication) Alzheimer’s Disease Dementia Multiple Sclerosis Parkinson’s Disease Neurological Disease Akassoglou Lab

Article January 11, 2024

Cellular Clean Energy: Can Mitochondria Make More Energy Without Collateral Damage?

New research from Gladstone may help in the development of new therapies that target the problem of cellular energy failure—a hallmark of Parkinson’s, Alzheimer’s, and aging in general

News Release Research (Publication) Alzheimer’s Disease Parkinson’s Disease Neurological Disease Nakamura Lab CRISPR/Gene Editing

Article April 18, 2023

Sugar Rush: Scientists Discover Key Role of Glucose in Brain Activity

New details on how healthy neurons metabolize glucose have implications for understanding neurodegenerative diseases

News Release Research (Publication) Parkinson’s Disease Alzheimer’s Disease Neurological Disease Nakamura Lab

Article August 6, 2021

Recycling a Cell’s Energy Centers to Ward Off Parkinson’s Disease

Gladstone researchers tracked mitochondria inside brain cells and uncovered a new recycling pathway that may be linked to disease

News Release Research (Publication) Parkinson’s Disease Neurological Disease Nakamura Lab

Article November 24, 2020

In Memory of David Traitel: Visionary Philanthropist and Champion of Parkinson’s Disease Research

Gladstone remembers a loyal partner in its fight against Parkinson’s disease

Donor Stories Parkinson’s Disease

Article October 14, 2020

Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases

The 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders

Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lab

Gladstone in the News October 2, 2020

Next Wave of Bay Area Neuroscience Companies: What Are They Doing Now?

San Francisco Business Times—Gabaeron, founded by Gladstone President Emeritus Bob Mahley, MD, PhD, and Therini Bio (formerly Medared), founded upon work by Senior Investigator Katarina Akassoglou, PhD, are among Bay Area biotech companies focusing on neurological diseases that collectively raised more than $3 billion from venture capital firms and the public capital markets in 2020.

Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Mahley Lab

Article August 27, 2020

Cellular Energy Audit Reveals Energy Producers and Consumers

A team at Gladstone Institutes screened the human genome for genes that play a role in making or consuming cellular energy

News Release Research (Publication) Parkinson’s Disease Heart Failure Neurological Disease Nakamura Lab Disease Models Genomics Metabolism

Gladstone in the News June 10, 2020

Researchers Profile Immune Cells Implicated in Neurodegenerative Disease

ImmunoFrontiers—Senior Investigator Katerina Akassoglou, PhD, describes her lab's recent discovery of the genetic mechanisms that drive brain inflammation in neurodegenerative diseases.

Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab

Article December 5, 2019

Meet Gladstone: Zak Doric

Zak describes how he used to pretend he hated math, and how grad school is teaching him more than just science.

Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Organization GO Graduate Students and Postdocs Profile Parkinson’s Disease Neurological Disease

January 27, 2016

Treating Parkinson’s Disease by Solving the Mysteries of Movement

In a pair of new studies, Gladstone scientists discovered a specific neural circuit that controls walking, and they found that input to this circuit is disrupted in Parkinson’s disease.

Kreitzer Lab Neurological Disease Optogenetics Parkinson’s Disease

Article September 13, 2015

Loss of Cellular Energy Leads to Neuronal Dysfunction in a Model of Neurodegenerative Disease

A new study from the Gladstone Institutes shows for the first time that impairments in mitochondria—the brain’s cellular power plants—can deplete cellular energy levels and cause neuronal dysfunction in a model of neurodegenerative disease.

Parkinson’s Disease Neurological Disease Nakamura Lab Basic Science Metabolism

Article July 6, 2010

Gladstone Scientists Establish Link Between Brain Activity and Parkinson’s Disease Symptoms

SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Neurological Disease (GIND) and Stanford University have shown how key circuits in the brain control movement.

Parkinson’s Disease Kreitzer Lab Optogenetics